Metabolomic Profile of Insulin Resistance Women with Systemic Lupus Erythematosus
Hormone and Metabolic Research · 01.07.2023 · 55 (07) · 487-492
DOI: 10.1055/a-2093-0260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.07.2023. Verfasst von Pamela Munguía-Realpozo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Systemic Autoimmune Diseases Research Unit, Specialties Hospital UMAE, Instituto Mexicano del Seguro Social, Puebla, Mexico. Hauptthemen laut MEDLINE: Insulin Resistance, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
The aims of this study were in systemic lupus erythematosus (SLE) patients: 1) to compare the metabolomic profile of insulin resistance (IR) with controls and 2) to correlate the metabolomic profile with other IR surrogates and SLE disease variables and vitamin levels. In this cross-sectional study, serum samples were collected from women with SLE (n=64) and gender- and age-matched controls (n=71), which were not diabetic. Serum metabolomic profiling was performed using UPLC-MS-MS (Quantse score). HOMA and QUICKI were carried out. Serum 25(OH)D concentrations were measured by chemiluminescent immunoassay. In women with SLE, the metabolomic Quantose score significantly correlated with HOMA-IR, HOMA2-IR, and QUICKI. Although concentrations of IR metabolites were not different between SLE patients and controls, fasting plasma insulin levels were higher and insulin sensitivity lower in SLE women. Interestingly, the Quantose IR score was significantly correlated with complement C3 levels (r=0.7; p=0.001). 25 (OH)D did not correlate with any metabolite or the Quantose IR index. Quantose IR may be a useful tool for IR assessment. There was a possible correlation between the metabolomic profile and complement C3 levels. The implementation of this metabolic strategy may help develop biochemical insight into metabolic disorders in SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Systemic Autoimmune Diseases Research Unit, Specialties Hospital UMAE, Instituto Mexicano del Seguro Social, Puebla, Mexico.
- Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.
- Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.
- Research in Health Coordination, Instituto Mexicano del Seguro Social, Puebla, Mexico.
ORCID-Profile: Claudia Mendoza-Pinto
Zitieren
APA
Munguía-Realpozo, P., Mendoza-Pinto, C., Etchegaray-Morales, I., Osorio-Peña, A. D., Vélez-Pelcastre, S., Escamilla-Márquez, M. A., Ayón-Aguilar, J., Méndez-Martínez, S., & García-Carrasco, M. (2023). Metabolomic Profile of Insulin Resistance Women with Systemic Lupus Erythematosus. Hormone and Metabolic Research, 55(07), 487-492. https://doi.org/10.1055/a-2093-0260
Vancouver
Munguía-Realpozo P, Mendoza-Pinto C, Etchegaray-Morales I, Osorio-Peña AD, Vélez-Pelcastre S, Escamilla-Márquez MA, et al. Metabolomic Profile of Insulin Resistance Women with Systemic Lupus Erythematosus. Hormone and Metabolic Research. 2023;55(07):487-492. doi:10.1055/a-2093-0260
BibTeX
@article{MunguaRealpozo2023,
author = {Munguía-Realpozo, Pamela and Mendoza-Pinto, Claudia and Etchegaray-Morales, Ivet and Osorio-Peña, Angel David and Vélez-Pelcastre, Sandra and Escamilla-Márquez, Marco Antonio and Ayón-Aguilar, Jorge and Méndez-Martínez, Socorro and García-Carrasco, Mario},
title = {Metabolomic Profile of Insulin Resistance Women with Systemic Lupus Erythematosus},
journal = {Hormone and Metabolic Research},
year = {2023},
volume = {55},
number = {07},
pages = {487--492},
doi = {10.1055/a-2093-0260}
}
EUVIMED